ALA — Arovella Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$109.35m
- AU$88.47m
- AU$0.53m
Annual cashflow statement for Arovella Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 1.12 | 0.528 | 1.08 | 2.07 | 3.69 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.54 | -6.27 | -6.4 | -6.91 | -6.93 |
| Capital Expenditures | -0.515 | -0.566 | -0.003 | -0.129 | -0.413 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | 0.098 | -0.05 | -0.019 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.515 | -0.566 | 0.095 | -0.179 | -0.432 |
| Financing Cash Flow Items | — | — | — | — | -1.29 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.8 | 6.19 | 5.41 | 14.6 | 15.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.74 | -0.646 | -0.896 | 7.54 | 8.16 |